as of 07-24-2026 3:46pm EST
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 538.3M | IPO Year: | 2020 |
| Target Price: | $10.00 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.13 | EPS Growth: | 53.02 |
| 52 Week Low/High: | $0.71 - $8.33 | Next Earning Date: | 05-01-2026 |
| Revenue: | $1,000,000 | Revenue Growth: | -82.52% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -54.54 | Index: | N/A |
| Free Cash Flow: | -39953000.0 | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Chief Technical Officer
Avg Cost/Share
$7.01
Shares
410
Total Value
$2,874.10
Owned After
86,380
SEC Form 4
Chief Technical Officer
Avg Cost/Share
$7.07
Shares
100
Total Value
$707.00
Owned After
86,380
SEC Form 4
Chief Technical Officer
Avg Cost/Share
$7.08
Shares
23,365
Total Value
$165,424.20
Owned After
86,380
SEC Form 4
Chief Medical Officer
Avg Cost/Share
$7.01
Shares
30,000
Total Value
$210,300.00
Owned After
136,219
SEC Form 4
Director
Avg Cost/Share
$4.00
Shares
62,500
Total Value
$250,000.00
Owned After
318,608
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | STTK | Chief Technical Officer | Jul 2, 2026 | Sell | $7.01 | 410 | $2,874.10 | 86,380 | |
| Shukla Abhinav A. | STTK | Chief Technical Officer | Jul 1, 2026 | Sell | $7.07 | 100 | $707.00 | 86,380 | |
| Shukla Abhinav A. | STTK | Chief Technical Officer | Jun 30, 2026 | Sell | $7.08 | 23,365 | $165,424.20 | 86,380 | |
| Pandite Arundathy N. | STTK | Chief Medical Officer | Jun 30, 2026 | Sell | $7.01 | 30,000 | $210,300.00 | 136,219 | |
| SIEGALL CLAY B | STTK | Director | Jun 9, 2026 | Buy | $4.00 | 62,500 | $250,000.00 | 318,608 |
SEC 8-K filings with transcript text
May 7, 2026 · 100% conf.
1D
+8.95%
$6.82
5D
+10.81%
$6.94
20D
+36.63%
$8.55
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.ce06d217.1784639224.d41cd3a8
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
Mar 5, 2026 · 100% conf.
1D
-2.10%
$4.55
Act: +17.65%
5D
-10.83%
$4.15
20D
-1.21%
$4.59
sttk-202603050001680367FALSE00016803672026-03-052026-03-05
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2026
Shattuck Labs, Inc. (Exact name of registrant as specified in its charter)
Delaware001-3959381-2575858 (State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification Number)
500 W. 5th Street, Suite 1200 Austin, TX 78701
(Address of principal executive offices including zip code)
(512) 900-4690
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuance to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.0001 per shareSTTKThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act☐
Item 2.02 Results of Operations and Financial Condition
On March 5, 2026, Shattuck Labs, Inc. issued a press release announcing its financial results for the year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated herein shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits Exhibits
Exhibit NumberDescription of Exhibit
99.1Press release issued by Shattuck Labs, Inc. regarding its financial results for the year ended December 31, 2025, dated March 5, 2026
104The cover page from the Company’s Current Report on Form 8-K formatted in Inline XBRL.
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Shattuck Labs, Inc.
Date: March 5, 2026 By:/s/ Dr. Taylor Schreiber
Dr. Taylor Schreiber Chief Executive Officer (principal executive officer)
3
Nov 6, 2025 · 100% conf.
1D
-3.08%
$1.90
Act: +2.29%
5D
-11.82%
$1.73
Act: -6.36%
20D
-14.31%
$1.68
Act: +57.76%
sttk-202511060001680367TRUEThis Amendment to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 6, 2025 (the “Original 8-K”) is being filed to correct typographical errors in the Original 8-K.00016803672025-11-062025-11-06
(Amendment No. 1)
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025
Shattuck Labs, Inc. (Exact name of registrant as specified in its charter)
Delaware001-3959381-2575858 (State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification Number)
500 W. 5th Street, Suite 1200 Austin, TX 78701
(Address of principal executive offices including zip code)
(512) 900-4690
(Registrant’s telephone number, including area code)
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuance to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.0001 per shareSTTKThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act☐
Explanatory Note: This Amendment to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 6, 2025 (the “Original 8-K”) is being filed to correct typographical errors in the Original 8-K. Item 2.02 Results of Operations and Financial Condition. On November 6, 2025, Shattuck Labs, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated herein shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits. Exhibits
Exhibit NumberDescription of Exhibit
99.1Press release issued by Shattuck Labs, Inc. regarding its financial results for the quarter ended September 30, 2025, dated November 6, 2025.
104The cover page from the Company’s Current Report on Form 8-K formatted in Inline XBRL.
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Shattuck Labs, Inc.
Date: November 6, 2025 By:/s/ Dr. Taylor Schreiber
Dr. Taylor Schreiber Chief Executive Officer (principal executive officer)
3
See how STTK stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "STTK Shattuck Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.